Screening, Fermentation, Isolation, and Characterization of Trypanomycin, a New Antibiotic
Open Access
- 1 May 1972
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 1 (5) , 385-391
- https://doi.org/10.1128/aac.1.5.385
Abstract
A Streptomyces strain which is similar to S. diastatochromogenes (Krainsky) Waksman et Henrici 1948 sensu Hütter (1967) was found to produce a new antibiotic designated trypanomycin. The red-pigment antibiotic, which has novel trypanocidal activity in vitro and in vivo, was isolated from a C-, N-, and iron-containing culture of the strain IMET JA 10081/9 by extraction with organic solvents, transfer into the aqueous phase, reextraction with organic solvents at p H 6.8, precipitation by hydrocarbons, and purification by chromatographic methods. Trypanomycin has indicator properties. The main constituents of the antibiotic mixture are readily soluble in water and are very stable in distilled water at room temperature (28 C) for 24 hr. The composition of the base of trypanomycin A 2 (melting point, 175 to 183 C) corresponds to the empirical formula C 41–42 H 52-56 NO 21-22 . The absorption spectra in the ultraviolet and visible regions are very similar to those of the 4,5,8-trioxyanthrachinones. Trypanomycin has strong antiprotozoal activity, e.g., against trypanosomes. The natural substance additionally inhibits the growth of gram-positive bacteria, stable as well as unstable L-forms of gram-negative bacteria, mycoplasmas, yeast protoplasts, and tumor cells in vitro. The LD 50 of trypanomycin in mice was 60 mg/kg when administered intravenously and 31 mg/kg on intraperitoneal administration. If the antibiotic was added to cultures of animal or human cells in vitro, mitotic inhibition and chromosomal aberrations resulted. Trypanomycin differs in its biological activities and chromatographic behavior from other anthracyclines, e.g., cinerubine A and B, daunomycin, adriamycin, nogalamycin, rutilantin, pyrromycin, cyclamycin, and ryemycin.Keywords
This publication has 9 references indexed in Scilit:
- [L forms of Escherichia coli K 12 (lambda). I. Induction and mode of multiplication].1971
- [Production and features of protoplasts from Schizosaccharomyces pombe].1969
- E. coli-Zellen mit intaktem und defektem Dunkelreparaturmechanismus für Strukturschäden an der DNS als Screening-Modell für die Suche nach potentiellen CarcinostaticaJournal of Basic Microbiology, 1969
- [A new microbiological screening method for the search for potential carcinostatic and virostatic agents with action on the nucleic acid metabolism].1968
- [Determination of the cytostatic activity of antibiotics and synthetic compounds on Ehrlich ascite carcinoma cells permanently in vitro in suspension form with the help of the electronic particle counter "TuR" ZG1].1968
- Mutants of Escherichia coli permeable to actinomycin.Proceedings of the National Academy of Sciences, 1967
- Über einen in vitro in Suspension wachsenden permanenten Stamm von Ehrlich-AscitestumorzellenPharmacology, 1965
- Agar-diffusion method for the screening of anticancer substances by phage induction.1965
- [ANTHRACYCLINONES AND ANTHRACYCLINES. (RHODOMYCINONE, PYRROMYCINONE AND THEIR GLYCOSIDES)].1963